East White Plains, NY1 Active Studies

Myeloproliferative Neoplasms Clinical Trials in East White Plains, NY

Find 1 actively recruiting myeloproliferative neoplasms clinical trials in East White Plains, NY. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
18
Enrolling

Recruiting Myeloproliferative Neoplasms Studies in East White Plains

About Myeloproliferative Neoplasms Clinical Trials in East White Plains

Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.

There are currently 1 myeloproliferative neoplasms clinical trials recruiting participants in East White Plains, NY. These studies are seeking a combined 18 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myeloproliferative Neoplasms Clinical Trials in East White Plains — FAQ

Are there myeloproliferative neoplasms clinical trials in East White Plains?

Yes, there are 1 myeloproliferative neoplasms clinical trials currently recruiting in East White Plains, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in East White Plains?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the East White Plains research site will contact you about next steps.

Are clinical trials in East White Plains free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many East White Plains studies also compensate for your time and travel.

What myeloproliferative neoplasms treatments are being tested?

The 1 active trials in East White Plains are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.

Data updated September 6, 2026 from ClinicalTrials.gov